ArticleInternal and emergency medicine2025
Association between step-down disposition based on the HACOR score and mortality in ED patients treated with non-invasive ventilation.
Article in Internal and emergency medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this retrospective study, we aimed to find reliable criteria that allow the identification of patients, treated with NIV for acute respiratory failure in the High-Dependency Unit in the earliest phase, who could continue treatment safely in the ordinary ward. We included all patients treated with NIV in the ED-HDU at Careggi University-Hospital, from July 2021 to December 2022. The HACOR score was calculated daily, and the discharge to the ward was considered Appropriate in the presence of the following criteria: 1) HACOR score ≤ 2; 2) not being dependent on NIV, which meant the possibility of alternating NIV with conventional oxygen treatment or High-Flow Nasal Cannula. The primary endpoint was all-cause in-hospital mortality. We included 297 patients, with a mean age of 79 ± 11 years, 57% female, 69% with hypercapnic respiratory failure. After 24 h, the HACOR score was ≤ 2 in 113 (38%) patients, with a mortality of 11% vs 21% for those with an HACOR score > 2 (p = 0.029). In total, 235 (79%) patients were transferred to the general ward, 110 as Inappropriate and 125 as Appropriate. In-hospital mortality rate was higher in the Inappropriate than in the Appropriate group (21% vs 7%, p = 0.004). After excluding the 64 patients treated with NIV as the ceiling treatment, 28 in the "Appropriate transfer" and 36 "Inappropriate transfer", we confirmed the increased mortality in patients with inappropriate transfer (14% vs 4%, p = 0.026). Therefore, patients with an HACOR score ≤ 2, not dependent on NIV, could be safely transferred to the ordinary ward to continue their ventilatory support.
Indexed as
Identifiers
41233687What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.